Cadrenal Therapeutics, Inc. (CVKD)

NASDAQ

$0.87

$--

(0.00%)

Pre-Market

Cadrenal Therapeutics, Inc. (CVKD) Live Price Chart

Last updated: ⁦2026-10-13 12:28:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Cadrenal Therapeutics, Inc. (CVKD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.87, with a market capitalisation of $3.25M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.82 to $14.50. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3.25M
Open	$0.87
Day's High	$101.25
Day's Low	$0.82
Previous Close	$0.87
Volume	5.00
Average Volume	463.89K
P/E Ratio	--
52-Week High	$14.50
52-Week Low	$0.82
Dividend Yield	--
Earnings Date	--

Cadrenal Therapeutics, Inc. (CVKD) Pre-Market Stock Price

Cadrenal Therapeutics, Inc. (CVKD) is trading at $0.87 in pre-market trading as of 2026-10-13 12:08:00, down 0.28% ($0.00) from the previous close of $0.87

Pre-market trading shows how investors are pricing CVKD before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Cadrenal Therapeutics, Inc. (CVKD) 7-Day Stock Price Change

Over the past seven days, Cadrenal Therapeutics, Inc. (CVKD) moved from $0.94 to $0.87, representing a decline of 7.47% ($0.07).

The stock traded between $0.82 and $1.07 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 372.34 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

CVKD 52-Week Price Position

Position in Range: 0.4%

52W Low$0.82

52W High$14.50

CVKD is currently trading at $0.87, placing it 0.4% of the way from its 52-week low of $0.82 to its 52-week high of $14.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cadrenal Therapeutics, Inc. (CVKD)?

Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to treat heparin-induced thrombocytopenia (HIT), a deadly immune-mediated thrombotic disorder. The pipeline includes two additional clinical-stage assets: tecarfarin and frunexian. Tecarfarin is an oral vitamin K antagonist (VKA) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation. Frunexian is a first-in-class, Phase 2-ready intravenous Factor XIa inhibitor designed for acute care settings where contact activation of coagulation by medical devices or artificial surfaces.

Cadrenal Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	5
Exchange	NASDAQ
Company Website	https://www.cadrenal.com

How to Buy Cadrenal Therapeutics, Inc. (CVKD) Stock on MEXC

Eligible investors can buy real shares of Cadrenal Therapeutics, Inc. (CVKD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CVKD and Place Your Order

Open the RealStocks trading page and search for CVKD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cadrenal Therapeutics, Inc. (CVKD) stock price today?

Cadrenal Therapeutics, Inc. (CVKD) is currently trading at $ 0.87, down 0.28% ($0.00) from the previous close of $ 0.87. Intraday prices update in real time during regular trading hours.

2.Is CVKD stock going up or down today?

As of 2026-10-13 12:08:00, CVKD is trading at $ 0.87, down 0.28% ($0.00) from its previous close of $ 0.87. The stock has traded between $ 0.82 and $ 101.25 during today’s regular session. Past price movements do not guarantee future results.

3.What is CVKD pre-market price?

As of 2026-10-13 12:08:00, CVKD is trading at $ 0.87 in pre-market trading, down 0.28% ($0.00) from the previous close of $ 0.87. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CVKD after-hours price?

As of 2026-10-13 12:08:00, CVKD is trading at $ 0.87 in after-hours trading, down 0.16% ($0.00) from the regular-session close of $ 0.87. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CVKD stock trading now?

CVKD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CVKD sit relative to its 52-week high and low?

Over the past 52 weeks, CVKD has traded between a low of $ 0.82 and a high of $ 14.50. At $ 0.87, the stock is positioned 0.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cadrenal Therapeutics, Inc. in?

Cadrenal Therapeutics, Inc. (CVKD) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cadrenal Therapeutics, Inc.'s market capitalisation and where is it listed?

Cadrenal Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 3.25M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CVKD valued in terms of P/E ratio and EPS?

CVKD trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.24. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cadrenal Therapeutics, Inc. pay a dividend?

Cadrenal Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.